Spotlight on pomalidomide: could less be more?

Leukemia. 2017 Sep;31(9):1987-1989. doi: 10.1038/leu.2017.156. Epub 2017 May 22.
No abstract available

MeSH terms

  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / economics
  • Adjuvants, Immunologic / pharmacokinetics
  • Adjuvants, Immunologic / therapeutic use*
  • Dexamethasone / administration & dosage
  • Drug Administration Schedule
  • Drug Costs
  • Humans
  • Multiple Myeloma / drug therapy*
  • Survival Analysis
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Thalidomide / economics
  • Thalidomide / pharmacokinetics
  • Thalidomide / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Thalidomide
  • Dexamethasone
  • pomalidomide